Display options
Cite
Pons D, Jukema JW. Epigenetic histone acetylation modifiers in vascular remodelling - new targets for therapy in cardiovascular disease. Neth Heart J. 2008;16(1):30-2doi: 10.1007/BF03086114.
Pons, D., & Jukema, J. W. (2008). Epigenetic histone acetylation modifiers in vascular remodelling - new targets for therapy in cardiovascular disease. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 16(1), 30-2. https://doi.org/10.1007/BF03086114
Pons, D, and Jukema, J W. "Epigenetic histone acetylation modifiers in vascular remodelling - new targets for therapy in cardiovascular disease." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 16,1 (2008): 30-2. doi: https://doi.org/10.1007/BF03086114
Pons D, Jukema JW. Epigenetic histone acetylation modifiers in vascular remodelling - new targets for therapy in cardiovascular disease. Neth Heart J. 2008;16(1):30-2. doi: 10.1007/BF03086114. PMID: 18612391; PMCID: PMC2442775.
Copy Download .nbib Format: NLM
Share it on

Neth Heart J. 2008;16(1):30-2. doi: 10.1007/BF03086114.

Epigenetic histone acetylation modifiers in vascular remodelling - new targets for therapy in cardiovascular disease.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

D Pons, J W Jukema

Affiliations

  1. Department of Cardiology, Leiden University Medical Centre, Leiden, and the Interuniversity Cardiology Institute of the Netherlands, Utrecht, the Netherlands.

PMID: 18612391 PMCID: PMC2442775 DOI: 10.1007/BF03086114

[No abstract available.]

References

  1. FASEB J. 2006 Jul;20(9):1418-30 - PubMed
  2. Circulation. 2005 Oct 18;112(16):2417-25 - PubMed
  3. J Atheroscler Thromb. 2003;10(4):239-45 - PubMed
  4. J Biol Chem. 2003 Jan 24;278(4):2309-16 - PubMed
  5. Circulation. 2003 Jul 29;108(4):464-71 - PubMed
  6. Mol Cell Biol. 2001 Oct;21(20):7065-77 - PubMed
  7. FASEB J. 2004 Dec;18(15):1897-9 - PubMed
  8. J Biol Chem. 1997 Nov 7;272(45):28171-4 - PubMed
  9. Atherosclerosis. 1999 Apr;143(2):307-13 - PubMed
  10. Mol Cell. 2002 Mar;9(3):625-36 - PubMed
  11. Nature. 1997 Sep 25;389(6649):349-52 - PubMed
  12. Science. 2001 Aug 10;293(5532):1074-80 - PubMed
  13. J Atheroscler Thromb. 2006 Aug;13(4):183-91 - PubMed
  14. J Am Coll Cardiol. 2005 Sep 20;46(6):1093-100 - PubMed
  15. Biochem J. 2003 Mar 15;370(Pt 3):737-49 - PubMed
  16. FASEB J. 2005 Dec;19(14):1998-2004 - PubMed
  17. J Mol Cell Cardiol. 2005 Oct;39(4):667-79 - PubMed
  18. Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10604-9 - PubMed
  19. J Biol Chem. 2003 Jan 24;278(4):2758-66 - PubMed
  20. Curr Drug Metab. 2007 May;8(4):383-93 - PubMed
  21. FEBS Lett. 2006 Oct 2;580(22):5177-84 - PubMed
  22. J Biol Chem. 1999 Jun 11;274(24):17342-52 - PubMed
  23. Pharmacogenet Genomics. 2006 Oct;16(10):747-54 - PubMed
  24. J Biol Chem. 1999 Dec 3;274(49):34940-7 - PubMed

Publication Types